The purpose was to investigate whether differences in equine hoof shape, which are inferred to alter foot function, are accompanied by differences in morphology of the laminar junction. Ten fore feet from adult horses were segregated into normal and low-angle groups, depending on the dorsal angle of the hoof wall. Twenty measurements of external hoof shape and four of the enclosed distal phalanx were tested for differences between groups, and for intragroup correlations. Three measurements of laminar morphology (spacing, orientation and degree of bend) were recorded for samples of up to 50 primary epidermal laminae at each of 20 sample sites. Sites were distributed over the foot in 5 circumferential columns and 4 proximodistal rows. Intergroup differences were investigated, as were correlations among sample sites of the laminar variables with the shape measurements. Results show differences in hoof shape between groups (but not bone shape) and laminar morphology. Six shape measurements are significantly different between groups: dorsal angle, medial and lateral angles, lateral sole width, solar circumference, and dorsal length. In the normal group, shape measurements show patterns of correlation among regions of the hoof, and between hoof and bone measurements. In the low-angle group, shape correlations occur largely within one region of the hoof (the heels) and in the bone measurements. Laminar spacing tends to be nonsignificantly greater in the low-angle group, while variances for laminar spacing and orientation are significantly greater in this group. Laminar spacing correlates with bone width and coronary circumference (CC) of the hoof in the normal group, but only with CC in the low-angle group. When taken as a whole, and interpreted in light of a model of foot mechanical function, the results appear to indicate a deterioration in structural coherence of the foot in the low-angle group.
The PCO system tracked changes in CO in a similar direction as the LiDCO system. The PCO system provided better agreement with LiDCO measurements over time when hemodynamic conditions were similar to those during initial calibration. Recalibration of the PCO system is recommended when hemodynamic conditions or pressure waveforms are altered appreciably.
The objective of the study was to compare 3 methods for calculating the area under the curve (AUC) for plasma glucose and nonesterified fatty acids (NEFA) after an intravenous epinephrine (EPI) challenge in dairy cows. Cows were assigned to 1 of 6 dietary niacin treatments in a completely randomized 6 × 6 Latin square with an extra period to measure carryover effects. Periods consisted of a 7-d (d 1 to 7) adaptation period followed by a 7-d (d 8 to 14) measurement period. On d 12, cows received an i.v. infusion of EPI (1.4 μg/kg of BW). Blood was sampled at -45, -30, -20, -10, and -5 min before EPI infusion and 2.5, 5, 10, 15, 20, 30, 45, 60, 90, and 120 min after. The AUC was calculated by incremental area, positive incremental area, and total area using the trapezoidal rule. The 3 methods resulted in different statistical inferences. When comparing the 3 methods for NEFA and glucose response, no significant differences among treatments and no interactions between treatment and AUC method were observed. For glucose and NEFA response, the method was statistically significant. Our results suggest that the positive incremental method and the total area method gave similar results and interpretation but differed from the incremental area method. Furthermore, the 3 methods evaluated can lead to different results and statistical inferences for glucose and NEFA AUC after an EPI challenge.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.